Abstract:BACKGROUND:Chemotherapy causes breakdown of the intestinal barrier, which may lead to bacterial translocation. Paclitaxel, an anti-tubulin agent, has many side effects; however, its effect on the intestinal barrier is unknown. Previous studies show that granulocyte colony-stimulating factor (G-CSF) plays an important role in modulating intestinal barrier function, but these studies are not conclusive. Here, we investigated the effects of paclitaxel on the intestinal barrier, and whether G-CSF could prevent paclitaxel-induced bacterial translocation.METHODS:Twenty-four male Sprague-Dawley rats were divided into three groups: control group, paclitaxel group and paclitaxel + G-CSF group. Intestinal permeability was measured by the urinary excretion rates of lactulose and mannitol administered by gavage. The mesenteric lymph nodes, spleen and liver were aseptically harvested for bacterial culture.Endotoxin levels and white blood cell (WBC) counts were measured and bacterial quantification performed using relative real-time PCR. Jejunum samples were also obtained for histological observation. Intestinal apoptosis was evaluated using a fragmented DNA assay and terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate(dUTP)-biotin nick end-labeling staining. One-way analysis of variance and Fisher's exact test were used to compare differences between groups.RESULTS:Paclitaxel induced apoptosis in 12.5% of jejunum villus cells, which was reduced to 3.8% by G-CSF treatment.Apoptosis in the control group was 0.6%. Paclitaxel treatment also resulted in villus atrophy, increased intestinal permeability and a reduction in the WBC count. G-CSF treatment resulted in increased villus height and returned WBC counts to normal levels. No bacterial translocation was detected in the control group, whereas 6/8, 8/8, and 8/8 rats in the paclitaxel group were culture-positive in the liver, spleen and mesenteric lymph nodes, respectively. Bacterial translocation was partially inhibited by G-CSF.CONCLUSIONS:Paclitaxel disrupts the intestinal barrier, resulting in bacterial translocation. G-CSF treatment protects the intestinal barrier, prevents bacterial translocation, and attenuates paclitaxel-induced intestinal side-effects.

Maitake Beta-Glucan Promotes Recovery of Leukocytes and Myeloid Cell Function in Peripheral Blood from Paclitaxel Hematotoxicity

Ganoderma spore lipid protects mouse bone marrow mesenchymal stem cells and hematopoiesis from the cytotoxicity of the chemotherapeutic agent

A Novel Bone Marrow Targeted Gadofullerene Agent Protect Against Oxidative Injury in Chemotherapy

Lentinan Mitigates Therarubicin-Induced Myelosuppression by Activating Bone Marrow-Derived Macrophages in an MAPK/NF-κB-dependent Manner

Beneficial Modulatory Effects of Treatment With Bone Marrow Lysate on Hematopoietic Stem Cells and Myeloid Cells in Tumor-Bearing Mice

Mesenchymal stem cells therapy enhances the efficacy of pregabalin and prevents its motor impairment in paclitaxel-induced neuropathy in rats: Role of Notch1 receptor and JAK/STAT signaling pathway

Ganoderma spore lipid ameliorates docetaxel, cisplatin, and 5-fluorouracil chemotherapy-induced damage to bone marrow mesenchymal stem cells and hematopoiesis

Along the gut-bone marrow signaling pathway: Use of longan polysaccharides to regenerate blood cell after chemotherapy-induced myelosuppression

Polysaccharide from spore of Ganoderma lucidum ameliorates paclitaxel-induced intestinal barrier injury: Apoptosis inhibition by reversing microtubule polymerization

Gamma-Fe2O3 nanoparticles increase therapeutic efficacy of combination with paclitaxel and anti-ABCG2 monoclonal antibody on multiple myeloma cancer stem cells in mouse model.

Therapeutic Efficacy of Bifidobacterium Longum-Mediated Human Granulocyte Colony-Stimulating Factor And/Or Endostatin Combined with Cyclophosphamide in Mouse-Transplanted Tumors

Maitake mushroom extract in myelodysplastic syndromes (MDS): a phase II study

The role of growth factor administration and T-cell recovery after peripheral blood progenitor cell transplantation in the treatment of solid tumors: results from a randomized comparison of G-CSF and GM-CSF

Role of Granulocyte Colony-Stimulating Factor in Paclitaxel-Induced Intestinal Barrier Breakdown and Bacterial Translocation in Rats.

Transduction of Mesenchymal Stem Cells with Multidrug Resistance Gene Provides Protection for Bone Marrow Toxicity after Being Transplanted into a Nude Mice Model.

Paclitaxel-Fe3O4 nanoparticles inhibit growth of CD138(-) CD34(-) tumor stem-like cells in multiple myeloma-bearing mice.

The Effects of Arctigenin-Valine Ester on Chemotherapy-Induced Myelosuppression in Mice.

[Effects of the Mobilization with AMD3100, Granulocyte-Colony-stimulating Factor (G-CSF) Alone and in Combination on the Immunological Function of the Lymphocytes in Mice].

Particulate Beta-Glucan Modulates Myeloid-Derived Suppressor Cells (MDSC) Activity in Tumor-Bearing Mice and Lung Cancer Patients (TUM4P.931)

Granulocyte colony-stimulating factor increases the therapeutic efficacy of bone marrow mononuclear cell transplantation in cerebral ischemia in mice

The Effects Of P38 Mapk Inhibition Combined With G-Csf Administration On The Hematoimmune System In Mice With Irradiation Injury